Live Webcasts From San Francisco on June 12 and New York on June 14
SAN DIEGO, June 6 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq:
FVRL), a biopharmaceutical company developing patient-specific
immunotherapies for the treatment of cancer, today announced that it will
present at two upcoming investor conferences.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)
John P. Longenecker, Ph.D., President and Chief Executive Officer of
Favrille, will present at the Pacific Growth Equities Life Sciences Growth
Conference at 10:30 a.m. Pacific time on Monday, June 12, 2006. The
conference will be held at the InterContinental Mark Hopkins Hotel in San
Francisco.
Dan Gold, Ph.D., Chief Scientific Officer of Favrille, will present at
the Needham Biotechnology & Medical Technology Conference at 2:00 p.m.
Eastern time on Wednesday, June 14, 2006. The conference will be held at
the New York Palace Hotel in New York City.
Live webcasts of both presentations can be accessed at
http://www.favrille.com. Replays will be available approximately one hour after
each presentation and archived for one month.
About Favrille, Inc.
Favrille, Inc. is a biopharmaceutical company focused on the research,
development and commercialization of targeted immunotherapies for the
treatment of cancer and other diseases of the immune system. The Company's
lead product candidate, FavId, is based upon unique genetic information
extracted from a patient's tumor. FavId is currently under investigation in
a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL
and Phase 2 clinical trials in other B-cell NHL indications. The Company is
developing additional applications based on its immunotherapy expertise and
proprietary cost-effective manufacturing technology, including a second
product candidate, FAV-201, for the treatment of T-cell lymphoma.
Company Contact:
Pete De Spain
Associate Director,
Investor Relations & Corporate Communications
Favrille, Inc.
(858) 526-2426
pdespain@favrille.com
SOURCE Favrille, Inc.
 back to top
Related links:
http://www.favrille.com/
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Pete De Spain, Associate Director, Investor
Relations & Corporate Communications of Favrille, Inc.,
+1-858-526-2426, pdespain@favrille.com
|
